SynthesisMedicine2017

Efficacy and safety of anti-PD-1 and anti-PD-1 combined with anti-CTLA-4 immunotherapy to advanced melanoma: A systematic review and meta-analysis of randomized controlled trials.

Chunyan Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.